The 2023 BIO International Convention is back to stand up for science! Bioasis (represented by John Proffett of Shadow Lake Group) will be meeting with potential partners 🤝
🗓️ June 5-8, 2023 | Boston Convention & Exhibition Center
Learn more:
bio.org/events/bio-int…
Curious about how Bioasis Technologies is breaking through the blood-brain barrier to develop innovative therapies for neurological diseases?
🎥 Check out our video to learn more about the xB3 platform
At Bioasis Technologies, we believe everyone deserves access to life-changing therapies for challenging neurological diseases.
That's why our team is leveraging our xB3 platform to develop novel therapies that can cross the blood-brain barrier & provide hope to patients in need.
🗓 May is #BrainTumorAwarenessMonth, and it's an important time to show support for all those affected by brain cancers.
Let's use this month to raise awareness, educate others, and show compassion for those living with brain cancer.
🗓️ May is #MSAwarenessMonth and Bioasis is committed to improving the lives of those affected by Multiple Sclerosis through innovative treatments like CRES101 for optic neuritis associated with MS.
With 1.25 billion people worldwide affected by neurological diseases, the need for effective treatments has never been greater 🧠
We're dedicated to delivering innovative solutions that make a difference in the lives of patients.
Find out more:
bit.ly/313Wk9L
Studies have highlighted the role of mutations in the GBA gene as a genetic risk factor for Parkinson's disease.
Our proprietary xB3 platform shows potential as a delivery method for therapeutics targeting the GBA gene & its related pathways.
Details:
bit.ly/3GEDIir
Our proprietary xB3 platform enables the delivery of therapeutics into the brain 💊 🧠
It transports molecules across the blood-brain barrier & into the brain, where they can effectively treat neurological disorders.
Learn more:
bit.ly/3nuTpP1
At Bioasis, we're dedicated to developing innovative therapies to treat rare and difficult-to-treat brain disorders.
Learn more about rare diseases 👉 bit.ly/3Zrs7e9
Bioasis is exploring strategic alternatives to enhance shareholder value, including partnerships, financing alternatives & remaining a standalone company.
Check out our website to learn about our ongoing efforts to drive value for our shareholders👇
bit.ly/3DvQmvF
Exciting news! Bioasis will be attending Bio-Europe Spring, one of the largest #biotechnology events in Europe.
This event brings together leading minds in the industry to share insights and forge new partnerships.
We can't wait to connect - learn more👇
bit.ly/3Lddzuc
It's Brain Awareness Week 🧠
We're dedicated to advancing brain health & developing therapies to treat neurological disorders. We support this important initiative & encourage everyone to get involved in raising awareness about brain health.
Details:
bit.ly/3ladfBJ
Today on #InternationalWomensDay, we celebrate the achievements of women in science globally.
At Bioasis, we're proud to recognize the contributions of women in science, who continue to break barriers & pave the way for new discoveries.
#IWD2023
Learn more👇
We've highlighted 3 indications that will be prioritized for development of CRES101:
✅ Guillain-Barré Syndrome
✅ Optic Neuritis associated with MS
✅ Chronic Inflammatory Demyelinating Polyneuritis
Details:
bit.ly/39ZGL7I
It's #RareDiseaseDay, a day to raise awareness about the challenges faced by people living with rare diseases.
At Bioasis, we're committed to developing treatments for rare brain diseases that affect millions of people worldwide.
Learn more👇
bit.ly/3lSSqL8
As we approach #RareDiseaseDay, we're reminded of the need for innovative treatments for these often-neglected conditions.
At Bioasis, we're proud to be working towards that goal by developing cutting-edge therapies for rare brain disorders.
Details👇
rarediseaseday.org
Millions of people around the world are affected by neurodegenerative diseases. 🌎
Developing effective treatments for these diseases remains a critical challenge.
Learn how our in-house development programs are designed to address this challenge: bit.ly/3JLCtNt
Bioasis is pleased to announce that all resolutions were passed by the requisite majority at its annual general meeting and is updating shareholders on its current financial condition.
Get the details👇
bit.ly/3HTmhMa
30K Followers 13K FollowingDiscover your next Investing Idea with Stock Alerts. Podcasts, News & more 📈 AI, Biotech, Crypto, Defense, Energy, Mining & More. Read paid disclosures.
909 Followers 4K FollowingDawn Van Zant Founder & Editor of @nvestorIdeas- Navigating the Future of Investment. Host of the cleantech podcast and lead researcher for investing trends
271 Followers 997 Followinglove Oil Invest in Oil/Gas Lost my other account. can’t find my user name. I love to ski and I invest in what is right. Oil/Gas.
1K Followers 3K FollowingBorn again since 2008 november 23. Christian's woman. Still believe. I am a work in progress. Chrétienne. Née de nouveau le 23 novembre 2008. Je m'améliore.
420 Followers 760 FollowingLe progrès s'amorce avec les fondements solides de la connaissance, du savoir scientifique et de toutes vérités que l'on peut vérifier. Pour un Québec libre! ⚜️
28 Followers 1K FollowingState certified h.s. English teacher, Dev. Writing, Theater, Work Skills & Community Health Worker college instructor, Theater Director.
All water is connected.
4.3M Followers 347 FollowingThe Hill is the premier source for policy and political news. Follow for tweets on what's happening in Washington, breaking news and retweets of our reporters.
5.4M Followers 247 FollowingCDC's official source for daily credible health & safety updates from Centers for Disease Control & Prevention. Privacy/comment policy: https://t.co/9LbZmE3Wzg
12.1M Followers 2K FollowingWe are the UN’s health agency - #HealthForAll. Always check our latest tweets for updated advice/information. We will respond to mis-and-disinformation.
2.6M Followers 3K FollowingResearch, News, and Commentary from Nature, the international science journal
For daily science news, get Nature Briefing: https://t.co/wGmQlQ8a4D
4.5M Followers 460 FollowingCutting-edge research, news, commentary, and visuals from the Science family of journals. Follow @NewsfromScience for stories from our News team.
560 Followers 434 FollowingIksuda is developing new generation antibody drug conjugates (ADCs) targeting difficult-to-treat haematological and solid tumours.
860 Followers 2K FollowingThe CMT Research Foundation has one mission: Deliver treatments and cures for #CMT. We fund the most promising research solely focused on drug development.
59 Followers 441 FollowingWe work exclusively on orphan drugs and advanced therapies. We advise, develop, write, review, and submit regulatory dossiers.
32K Followers 965 FollowingEarly stage tech investor. Dad of girls, Proud ex Aussie Digger. QLD'er, #SharkTankAU, pilot. Retweets my biz, may agree/not/desire to ridicule & poke fun.
64K Followers 180 FollowingManaging Partner, RA Capital Management. We build & invest in biotech companies. Scientist. Author, The Great American Drug Deal. https://t.co/ARVLrrTQU4
9K Followers 10K FollowingWe identify and catalyze the commercial potential of breakthrough #technologies & #innovations that benefit society.
#TinderforStartups #SharkTankonSteroids
12K Followers 6K FollowingCalifornia Life Sciences is the state’s most impactful life sciences membership org. advocating for the industry & its diverse innovation pipeline
20K Followers 16K FollowingFor 25 years we have produced fundamental investment research on quoted companies and funds. Our research is available for free from our website & RNS.
1K Followers 551 FollowingAims to establish an EMCR brain science platform to develop future leaders and to drive Australian brain science forward. @BrainAllianceAU. views are our own.
825 Followers 484 FollowingRoots Analysis is a specialist research firm focused on providing business research and consulting to the various industries.
21K Followers 1K FollowingOfficial Twitter handle of Takeda’s Oncology Business. We aspire to cure cancer, with inspiration from patients & innovation from everywhere. Guidelines below:
26K Followers 3K FollowingMove Money. Shift Power. Change Culture.
When the venture capital ecosystem evolves, women and nonbinary investors and founders succeed.
339 Followers 125 FollowingSachs Associates is a long established international conference company focused on BioPharma, MedTech & Digital Health events for Investment & Partnering.
725 Followers 979 FollowingOfficial Twitter page of the European Mediscience Awards, sponsored by SVB UK, taking place on Thursday 15 June 2023 #MediscienceAwards
7K Followers 1K FollowingCenterWatch is the global leader in providing clinical trial information to clinical research professionals working at sponsors, CROs and research sites.
3K Followers 2K FollowingA leading full-service global contract research organization that works to create customized solutions that advance new medications – from discovery to reality.